Diagnosing vascular (venous) invasion in colorectal carcinomas



Similar documents
How to report Upper GI EMR/ESD specimens

EMR Can anyone do this?

Renal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

Endoscopic Submucosal Dissection (E.S.D.) vs. Endoscopic Mucosal Resection (E.M.R.) in Colombia. Advocating E.M.R.

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

Pathologic Assessment Of The Breast And Axilla After Preoperative Therapy

HER2 Status: What is the Difference Between Breast and Gastric Cancer?

Cancer of the Cardia/GE Junction: Surgical Options

Endoscopic mucosal resection for treatment of early gastric cancer

OBJECTIVES By the end of this segment, the community participant will be able to:

Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical

The Staging of Colorectal Cancer: What s New in the Seventh Edition of The AJCC Cancer Staging Manual

Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group

Surveillance for Hepatocellular Carcinoma

Recommendations for cross-sectional imaging in cancer management, Second edition

Endoscopic Therapy for Early Esophageal Cancer: EMR and ESD

Multiple Primary and Histology Site Specific Coding Rules KIDNEY. FLORIDA CANCER DATA SYSTEM MPH Kidney Site Specific Coding Rules

Hepatocellular Carcinoma: What the hepatologist wants to know

Surgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科

PROTOCOL OF THE RITA DATA QUALITY STUDY

Bridging Techniques. What s between EMR and Traditional Surgery? Elisabeth C. McLemore, MD, FACS, FASCRS

MRI in Rectal Cancer. Kartik S Jhaveri, MD,FRCPC Director, Abdominal MRI Director, CME Program

GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER

Human Anatomy and Physiology II Laboratory

Practical Effusion Cytology

These parameters cannot, at the present time, be determined by non-invasive imaging techniques.

Challenges in gastric, appendiceal and rectal NETs Leuven,

The evolution of rectal cancer therapy. Objectives

Prognostic and Predictive Factors in Oncology. Mustafa Benekli, M.D.

Something Old, Something New.

Endoscopic Resection for Barrett s Esophagus and Early Cancer 2014 Masters of Minimally Invasive Surgery

ATLAS OF HEAD AND NECK PATHOLOGY THYROID PAPILLARY CARCINOMA

Case of the. Month October, 2012

Non-invasive evaluation of liver fibrosis: current clinical use and next perspectives (chronic hepatitis C)

Learning Luncheon 7: Endoscopic Mucosal Resection: When, Where and How?

Safe and Effective Surgery for Endometriosis Including Detection and Intervention for Ovarian Cancer

J Clin Oncol 28: by American Society of Clinical Oncology INTRODUCTION

Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012

Uterus myomatosus. 10-May-15. Clinical presentation. Incidence. Causes? 3 out of 4 women. Growth rate vary. Most common solid pelvic tumor in women

The recommendations made throughout this book are by the National Health and Medical Research Council (NHMRC).

A912: Kidney, Renal cell carcinoma

SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD

9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH

GENERAL CODING. When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis.

A 70-year old Man with Pleural Effusion

Risk stratification for colorectal cancer especially: the difference between sporadic disease and polyposis syndromes. Dr. med. Henrik Csaba Horváth

Breast Cancer Care & Research

Liver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco

Report series: General cancer information

Captivator EMR Device

Diagnosis and Prognosis of Pancreatic Cancer

Early mortality rate (EMR) in Acute Myeloid Leukemia (AML)

The Royal Marsden. Surgery for Gastric and GE Junction Cancer: primary palliative where and when? William Allum

Kidney Cancer OVERVIEW

Metastatic Breast Cancer...

Breast cancer close to the nipple: Does this carry a higher risk ofaxillary node metastasesupon diagnosis?

The evolving pathology of solitary fibrous tumours. Luciane Dreher Irion MREH / CMFT / NSOPS

Avastin in Metastatic Breast Cancer

PSA Testing 101. Stanley H. Weiss, MD. Professor, UMDNJ-New Jersey Medical School. Director & PI, Essex County Cancer Coalition. weiss@umdnj.

Intraobserver and Interobserver Reproducibility of WHO and Gleason Histologic Grading Systems in Prostatic Adenocarcinomas

Cytopathology Case Presentation #8

PRODYNOV. Targeted Photodynamic Therapy of Ovarian Peritoneal Carcinomatosis ONCO-THAI. Image Assisted Laser Therapy for Oncology

Update on Mesothelioma

micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved

EIN. (Endometrial Intraepithelial Neoplasia): Improved Criteria for diagnosing endometrial precancer. Stanley J. Robboy, MD, FCAP,

Rectal Cancer. To Radiate or not to radiate? Q: Should rectal cancer RT/CRT decisions be based solely on stage? 11/09/2014

Integrating Chemotherapy and Liver Surgery for the Management of Colorectal Metastases

Update on thyroid cancer surveillance and management of recurrent disease. Minimally invasive thyroid surgery

why? 75 percent The percentage of healthy individuals over age 40 who will become critically ill at some time in the future. 3

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? Telephone

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

Primary Care Management of Colorectal Cancer

Image SW Review the anatomy of the EAC and how this plays a role in the spread of tumors.

SECOND PRIMARY BREAST CANCERS FOLLOWING HAEMATOLOGIC MALIGNANCIES A CASE SERIES STUDY FARAH TANVEER PGY 3 DR.MEIR WETZLER DR.

October is Breast Cancer Awareness Month!

Cancer in Primary Care: Prostate Cancer Screening. How and How often? Should we and in which patients?

Lymph Nodes and Cancer What is the lymph system?

How To Use A Breast Cancer Test To Help You Choose Chemotherapy

Early Colonoscopy in Patients with Acute Diverticulitis Simon Bar-Meir, M.D.

Effect of Risk and Prognosis Factors on Breast Cancer Survival: Study of a Large Dataset with a Long Term Follow-up

Pathological assessment of the rectal cancer resection specimen

Analysis of Prostate Cancer at Easter Connecticut Health Network Using Cancer Registry Data

Sentinel Lymph Node Mapping for Endometrial Cancer. Locke Uppendahl, MD Grand Rounds

PANCREATIC AND PERIAMPULLARY TUMORS: PANCREATICODUODENECTOMY. Dr. Shailesh V. Shrikhande

Diagnosis and Treatment of Common Oral Lesions Causing Pain

Notice of Faculty Disclosure

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project

Transcription:

Diagnosing vascular (venous) invasion in colorectal carcinomas Improving reproducibility and potential pitfalls Gábor Cserni Bács-Kiskun County Teaching Hospital, Kecskemét & University of Szeged Hungary

Venous invasion (VI) whether portal or (porto-)caval http://www.hindawi.com/journals/grp/2012/309417/fig3/ is an independent prognostic factor for haematogenous metastasis and survival in CRC

Incidence with HE in previous reports: 9-28% Stewart CJR et al. Histopathology 2007;51:372-8.

VI in previous HE series HE 365/703 RC (52%) Talbot I et al. Histopathology 1981;5:141-63. HE 12/82 (22%) of previously reported as V0 CC Stewart CJR et al. Histopathology 2007;51:372-8.

Clues Orphan artery Protruding tongue Circumferential muscular wall Circumferential elastic layer

Orphan artery Circumferential muscular wall Circumferential elastic layer Protruding tongue

Orphan artery Circumferential muscular wall Circumferential elastic layer Protruding tongue

Intramural vs extramural Both impact on prognosis. Petersen VC et al. Gut 2002; 51:65-69. Sternberg A et al. J Clin Pathol 2002; 55:17-21.

Reproducibility 1 131 HE slides of pt3/pt4 CCs, 4 GI pathologists, St James Hospital, Leeds, UK Kappa 0.29 to 0.59 (poor to moderate agreement) elastic stain or standardized criteria Littleford SE et al. Histopathology 2009; 55:407-13.

Incidence with special stains in previous reports: 27-52% Stewart CJR et al. Histopathology 2007;51:372-8.

HE vs elastic stains EMVI: 18/75 (24%) 32/75 (43%) IMVI: 8/75 (11%) 30/75 (40%) Vass DG et al. J Clin Pathol 2004;57:769-72. 17/92 (18%) 57/92 (62%) Howlett CJ et al. J Clin Pathol 2009;62:1021-5. 290 (36%) vs 208 (46%) In Dukes stages A+B: 36/167 (22%) vs 37/113 (32%) p < 0.036 Abdulkader M et al. Histopathology 2006;49:487-92. 28/121 (23%) (2002) vs 81/121 (67%) (2007) Bogner B et al. Magyar Onkol 2009;53:107-13.

Venous invasion HE detected VI in 18% Orcein (elastica stain) detected VI in 71% 11/89 CRCs had synchronous metastasis (M1) 9 N+ (pn1 or pn2) all VI+ i.e. V1 Median follow-up of 17 months 9 further cases were diagnosed with metachronous distant metastasis 6 N+ and all VI+ Sejben I et al. JCP 2010;63(7):575-8.

Venous invasion Specificity and sensitivity for predicting distant metastasis: LN metastasis: 0.56 and 0.75, respectively Orcein detected VI: 0.39 and 1, respectively Elastic stains enable the detection of clinically relevant VI in greater frequency than HE stained histological slides. If nodal involvement is an indication for systemic chemotherapy, our data suggest that VI detected by the orcein stain should also be an indication for that. Sejben I et al. JCP 2010;63(7):575-8.

HE x40 x100 x100 x400

Orcein x40 x100 x100 x400

Orcein staining Orcein electively stains elastic fibres in an acidic-alcohol milieu. Deparaffination Staining with orcein solution overnight orcein D 0,1 g 70% alcohol (ethanol) 100 ml concentrated HCl 2 ml Differentiation with 70% alcohol Dehydratation, clearing, mounting

Suspected VI in muscularis pr NOT VI! Unsuspected VI in submucosa VI!

Reproducibility 2 40 HE slides, then 6w later 40 corresponding Movat-stained slides of CRCs (22 with unequivocal VI), 6 GI & 6 nongi pathologists, CANADA HE (kappa) Movat (kappa) GI 30% 58% NonGI 9% 35% All 20% (0.32) 46% (0.43) Kirsch R et al. AJSP 2013; 37:200-10.

Poststudy survey 9. Do you think that routine elastin staining of all blocks containing tumor should be introduced to facilitate the identification of venous invasion? 4/6 GI yes & 5/6 ngi yes 11. Would it be FEASIBLE to adopt routine elastin staining in your department? 4-5/6 GI yes & 4/6 ngi yes 12. What would be the reasons for you NOT routinely using an elastin stain to assess venous invasion? Cost, workforce constraints, both 1/6 GI & 4/6 ngi; other 1/6 GI & 4/6 ngi Kirsch R et al. AJSP 2013; 37:200-10.

Regarding costs and workload net benefits gained from the introduction of these special stains outweighed the small extra cost and effort and, in addition, saved time for the reporting pathologists. Abdulkader M et al. Histopathology 2006;49:487-92. About 13 128 HUF for a staining solution used for about 3 months, processing about 200 slides, about 66 HUF/slide (320 HUF = 1 Euro), about 20 cents/slide, i.e. 1 Euro/case

Reproducibility 3 Incidence & practice assessment in 8 hospitals (1450 CRCs), different cohorts of 20 (10) cases w/wo special stains, w/wo guidance, w/wo area selection, Delphi method - development of new set of criteria; VI and LVI together or separately, JAPAN Kappa for VI: not different 0.52 (HE) to 0.50 (elastica stain), 0.55 with criteria; but 0.62 with the new criteria Kojima M et al. J Clin Pathol 2013; 66:551-8.

Criterion Scanning at X4 to identify suspected lesions, then further assessment at higher power. Elastica: thick arteries surrounded by tumor cluster; if elastica-stained internal elastic membrane covering more than half of circumference (basis for diagnosis) is present VI even in the absence of accompanying artery, vascular structure or space. Kojima M et al. J Clin Pathol 2013; 66:551-8.

Potential pitfalls Pseudo-venous invasion Cserni G et al. J Clin Pathol 2013; 66:543-547

Capillary (A), venous (B,C) & arterial (D) invasion in CRC CD34 Orcein EVG Cserni G et al. J Clin Pathol 2013; 66:543-7.

Arterial (A, B) and venous (C, D) wall invasion Orcein Cserni G et al. J Clin Pathol 2013; 66:543-7.

Subserosal elastic lamina

Subserosal elastic lamina

Occasional submucosal elastic layer

Occasional submucosal elastic layer Diverticular mucosal protrusion

Periganglionic elastic fibres

Periganglionic elastic fibres

Periganglionic elastic fibres

Periganglionic elastic fibres

Postirradiation (noxious) changes Periglandular elastosis

Postirradiation (noxious) changes Periglandular elastosis

Postirradiation (noxious) changes Periglandular elastosis

Postirradiation (noxious) changes Periglandular elastosis

Postirradiation (noxious) changes Perimuscular elastosis

Postirradiation (noxious) changes Perimuscular elastosis (EVG)

Postirradiation (noxious) changes Perineural elastic fibres

Postirradiation (noxious) changes Perineural elastic fibres

Postirradiation (noxious) changes Perineural elastic fibres

Very rare perilymphoglandular elastic fibres

Very rare perilymphoglandular elastic fibres

Perifollicular elastic fibres (rectal ca)

Perifollicular elastic fibres (rectal ca)

Erythrocytes

Conclusions Routine elastic stains are valuable in identifying an important prognosticator of CRC. They double or triple the rate of VI. (This is often neglected) ODx This may improve reproducibility, but consensus based diagnostic criteria also help. Pseudo-VI should be distinguished from VI.